Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer

References

• Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer. Ann Glob Health. 2019;85:8.
   PubMed Web of Science ®Google Scholar
• Provencio M, Sánchez A, Garrido P, et al. New molecular targeted therapies integrated with radiation therapy in lung cancer. Clin Lung Cancer. 2010;11(2):91–97.
   PubMed Web of Science ®Google Scholar
• Page S, Milner-Watts C, Perna M, et al. Systemic treatment of brain metastases in non-small cell lung cancer. Eur J Cancer. 2020;132:187–198.
   PubMed Web of Science ®Google Scholar
• Wang S, Cang S, Liu D. Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer. J Hematol Oncol. 2016;9:34.
   PubMed Web of Science ®Google Scholar
• Lee DH. Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): the road to a success, paved with failures. Pharmacol Ther. 2017;174:1–21.
   PubMed Web of Science ®Google Scholar
• Bolha L, Ravnik-Glavač M, Glavač D. Circular RNAs: Biogenesis, function, and a role as possible cancer biomarkers. Int J Genomics. 2017;2017:6218353.
   PubMed Web of Science ®Google Scholar
• Arnaiz E, Sole C, Manterola L, et al. CircRNAs and cancer: Biomarkers and master regulators. Semin Cancer Biol. 2019;58:90–99.
   PubMed Web of Science ®Google Scholar
• Li C, Zhang L, Meng G, et al. Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer. J Cancer Res Clin Oncol. 2019;145(12):2875–2889.
   PubMed Web of Science ®Google Scholar
• Zhu LP, He YJ, Hou JC, et al. The role of circRNAs in cancers. Biosci Rep. 2017;37:BSR20170750.
   PubMed Web of Science ®Google Scholar
• Hong W, Xue M, Jiang J, et al. Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC). J Exp Clin Cancer Res. 2020;39(1):149.
   PubMed Web of Science ®Google Scholar
• Li X, Yang B, Ren H, et al. Hsa_circ_0002483 inhibited the progression and enhanced the taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p. Cell Death Dis. 2019;10(12):953.
   PubMedGoogle Scholar
• Zhong Y, Lin H, Li Q, et al. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis. Cancer Biomark. 2021;30(2):261–273.
   PubMed Web of Science ®Google Scholar
• Dong Y, Xu T, Zhong S, et al. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p. Life Sci. 2019;239:116984.
   PubMed Web of Science ®Google Scholar
• Guo C, Wang H, Jiang H, et al. Circ_0011292 enhances paclitaxel resistance in Non-Small cell lung cancer by regulating miR-379-5p/TRIM65 axis. Cancer Biother Radiopharm. 2020.
   Web of Science ®Google Scholar
• Wen C, Xu G, He S, et al. Screening circular RNAs related to acquired gefitinib resistance in non-small cell lung cancer cell lines. J Cancer. 2020;11(13):3816–3826.
   PubMed Web of Science ®Google Scholar
• Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287–314.
   PubMed Web of Science ®Google Scholar
• Bach DH, Kim D, Bae SY, et al. Targeting nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-resistant non-small-cell lung cancer cells. Mol Ther Nucleic Acids. 2018;11:455–467.
   PubMedGoogle Scholar
• Han Z, Zhou X, Li S, et al. Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/akt pathway. Oncol Rep. 2017;38(5):3064–3070.
   PubMed Web of Science ®Google Scholar
• Jin S, He J, Li J, et al. MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1. Thorac Cancer. 2018;9(10):1262–1270.
   PubMed Web of Science ®Google Scholar
• Lei Y, Guo W, Chen B, et al. Tumor‐released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‐small cell lung cancer. Oncol Rep. 2018;40(6):3438–3446.
   PubMed Web of Science ®Google Scholar
• Cao X, Lai S, Hu F, et al. miR-19a contributes to gefitinib resistance and epithelial mesenchymal transition in non-small cell lung cancer cells by targeting c-Met. Sci Rep. 2017;7(1):2939.
   PubMedGoogle Scholar
• Tang L, Xiong W, Zhang L, et al. circSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma. Oncogene. 2021;40(2):307–321.
   PubMed Web of Science ®Google Scholar
• Xu L, Feng X, Hao X, et al. CircSETD3 (hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth. J Exp Clin Cancer Res. 2019;38(1):98.
   PubMed Web of Science ®Google Scholar
• Wang J, Li X, Lu L, et al. Circular RNA hsa_circ_0000567 can be used as a promising diagnostic biomarker for human colorectal cancer. J Clin Lab Anal. 2018;32:e22379.
   PubMed Web of Science ®Google Scholar
• Huang Y, Dai Y, Wen C, et al. circSETD3 contributes to acquired resistance to gefitinib in Non-Small-Cell lung cancer by targeting the miR-520h/ABCG2 pathway. Mol Ther Nucleic Acids. 2020;21:885–899.
   PubMedGoogle Scholar
• Hu X, Mu Y, Wang J, et al. LncRNA TDRG1 promotes the metastasis of NSCLC cell through regulating miR-873-5p/ZEB1 axis. J Cell Biochem. 2019;122(9):969–982.
   Google Scholar
• Yu Y, Xing Y, Zhang Q, et al. Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression. IUBMB Life. 2021;73(1):92–107.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang B, Zhang P, et al. Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells. PLoS One. 2019;14(5):e0217181.
   PubMed Web of Science ®Google Scholar
• Wu DD, Li XS, Meng XN, et al. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1. Tumour Biol. 2016;37(8):10499–10506.
   PubMed Web of Science ®Google Scholar
• Zheng P, Eastman J, Vande Pol S, et al. PAT1, a microtubule-interacting protein, recognizes the basolateral sorting signal of amyloid precursor protein. Proc Natl Acad Sci USA. 1998;95(25):14745–14750.
   PubMed Web of Science ®Google Scholar
• Hirasawa A, Saito-Ohara F, Inoue J, et al. Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. Clin Cancer Res. 2003;9(6):1995–2004.
   PubMed Web of Science ®Google Scholar
• Li J, Yang Y, Peng Y, et al. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat Genet. 2002;31(2):133–134.
   PubMed Web of Science ®Google Scholar
• Gong H, Liu F, Liu X, et al. APPBP2 enhances non-small cell lung cancer proliferation and invasiveness through regulating PPM1D and SPOP. EBioMedicine. 2019;44:138–149.
   PubMed Web of Science ®Google Scholar